Thymus Regeneration, Immunorestoration, and Insulin Mitigation Extension Trial
NCT04375657
·
clinicaltrials.gov ↗
PHASE2
Phase
RECRUITING
Status
85
Enrollment
INDUSTRY
Sponsor class
Conditions
Epigenetic Aging
Immunosenescence
Interventions
COMBINATION_PRODUCT:
TRIIM Treatment
COMBINATION_PRODUCT:
Active Control
Sponsor
Intervene Immune, Inc.